Table 4 shows the bivariate correlations between LMI, baseline lean mass, and the change in lean mass after 6 months of treatment with TNF inhibitors in patients with RA according to clinical, laboratory, and inflammation-related variables. This evidence concerns the gene TNF and rheumatoid arthritis.